MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
KURA — Kura Oncology, Inc.
NasdaqKura Oncology, Inc.
$10.62
-0.03(-0.28%)
- O
- 10.73
- H
- 10.80
- L
- 10.29
- V
- 1.29M
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About KURA
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateAug 25, 2015
Employees260
Stock ExchangeNasdaq
Ticker SymbolKURA
Websitehttps://www.kuraoncology.com
Key Financial Statistics
| Market Cap | $947.43M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $7.36 - $13.90 |
| 52-Week Avg Volume | 1.73M |
| VWAP | $10.59 |
| Transactions | 15,101 |
| Total Recorded Bars | 2,779 days |